Switch to Wegovy from Mounjaro - Dose Conversion UK Guide

Clinically Proven UK Registered Pharmacy

Cheapest Switch to Wegovy UK Price - From £124.99

Switch to Wegovy at the cheapest UK price from £124.99 with expert dose conversion guidance and £20 off first order using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

How to Switch to Wegovy from Mounjaro: Complete UK Dose Conversion and Nausea Management Guide

Many patients considering how to switch to Wegovy from Mounjaro need clear guidance on dose conversion protocols and managing potential nausea during the transition. Both medications are GLP-1 receptor agonists approved for chronic weight management in the UK, but they contain different active ingredients requiring careful dose matching. This comprehensive guide, reviewed by our superintendent pharmacist Tarun Kumar (GPhC 2233073), provides evidence-based protocols for safely transitioning between these treatments whilst minimising gastrointestinal side effects.

Understanding the Switch to Wegovy from Mounjaro: Key Differences

When you switch to Wegovy from Mounjaro, you're transitioning from tirzepatide (a dual GIP/GLP-1 receptor agonist) to semaglutide (a selective GLP-1 receptor agonist). Whilst both medications work through GLP-1 pathways to reduce appetite and slow gastric emptying, Mounjaro's additional GIP activity may contribute to different tolerability profiles between the two treatments [1].

Clinical trials demonstrate that both medications achieve significant weight reduction, with the STEP programme showing semaglutide (Wegovy) produced average weight loss of 15-17% over 68 weeks, whilst the SURPASS trials showed tirzepatide (Mounjaro) achieved 15-22% weight reduction depending on dose [2]. The decision to switch to Wegovy from Mounjaro often relates to cost considerations, availability, or individual tolerability rather than efficacy differences.

From a practical standpoint, Wegovy offers a simpler dosing schedule with weekly injections up to a maximum of 2.4mg, compared to Mounjaro's range extending to 15mg weekly. At Cured Pharmacy, Wegovy is available from £124.99 subject to clinical assessment, making it a cost-effective alternative for many patients currently prescribed Mounjaro.

Dose Conversion Chart: Switch to Wegovy from Mounjaro Safely

There is no officially sanctioned direct dose equivalence when you switch to Wegovy from Mounjaro, as the medications have different mechanisms and potencies. However, UK prescribers typically follow conservative conversion protocols based on clinical experience and the relative efficacy data from respective trial programmes [3].

The general approach when switching to Wegovy from Mounjaro involves restarting Wegovy at a lower therapeutic dose rather than attempting exact milligram-for-milligram conversion. Most clinicians recommend beginning Wegovy at either the 0.5mg or 1mg dose depending on your current Mounjaro dose and tolerability, then titrating upward according to the standard Wegovy escalation schedule.

Recommended Conversion Protocol for Switch to Wegovy from Mounjaro

If you're currently on Mounjaro 2.5mg or 5mg, your prescriber will likely initiate Wegovy at 0.25mg weekly for four weeks, then increase to 0.5mg as per the standard titration schedule. For patients on Mounjaro 7.5mg to 12.5mg, starting Wegovy at 0.5mg or 1mg may be appropriate, bypassing the initial 0.25mg dose. Those on Mounjaro 15mg typically begin Wegovy at 1mg weekly, progressing toward the maximum 2.4mg dose over subsequent months [4].

The transition period between stopping Mounjaro and starting Wegovy should be minimal—typically beginning Wegovy the week after your last Mounjaro injection maintains therapeutic continuity whilst allowing the previous medication to clear. This approach, recommended by most UK weight management services, helps sustain appetite suppression and minimises rebound hunger during the switch to Wegovy from Mounjaro.

Managing Nausea When You Switch to Wegovy from Mounjaro

Nausea represents the most commonly reported side effect during the switch to Wegovy from Mounjaro, affecting approximately 20-44% of patients in clinical trials, particularly during dose escalation phases [5]. Interestingly, some patients transitioning from Mounjaro may experience less nausea with Wegovy if they previously struggled with tirzepatide's dual-agonist effects, whilst others may find semaglutide produces more pronounced gastrointestinal symptoms.

The severity and duration of nausea when you switch to Wegovy from Mounjaro typically correlates with the starting dose selected and how rapidly titration occurs. Following a conservative escalation schedule—spending at least four weeks at each dose level—significantly reduces the incidence and intensity of nausea compared to accelerated protocols.

Evidence-Based Strategies to Reduce Nausea During the Switch to Wegovy from Mounjaro

Dietary modifications prove remarkably effective in managing nausea when you switch to Wegovy from Mounjaro. Consuming smaller, more frequent meals throughout the day rather than three large meals reduces gastric distension and works synergistically with Wegovy's gastric-emptying effects. Avoiding high-fat, spicy, or heavily processed foods for the first 48 hours following each injection minimises triggering nausea, as these foods require longer gastric processing time.

Timing your Wegovy injection strategically can also influence nausea severity during the switch to Wegovy from Mounjaro. Many patients report better tolerability when administering injections in the evening before bed, allowing peak nausea periods to occur during sleep. Staying well-hydrated with small, frequent sips of water or ginger tea throughout the day supports gastric comfort, though avoiding large fluid volumes immediately before or after meals prevents excessive stomach distension [6].

If nausea persists despite these measures when you switch to Wegovy from Mounjaro, consult your prescriber about temporarily reducing your dose or extending the time spent at your current dose level before escalating further. In some cases, anti-emetic medications such as domperidone or prochlorperazine may be prescribed short-term to manage severe symptoms, though these should only be used under medical supervision.

Feature Mounjaro (Tirzepatide) Wegovy (Semaglutide)
Active Ingredient Tirzepatide (GIP/GLP-1) Semaglutide (GLP-1)
Injection Frequency Weekly Weekly
Starting Dose 2.5mg 0.25mg
Maximum Dose 15mg 2.4mg
Average Weight Loss 15-22% (68 weeks) 15-17% (68 weeks)
Common Side Effects Nausea, diarrhoea, constipation Nausea, diarrhoea, constipation
UK Price at Cured Pharmacy From £145.00 From £89.00
Supply Stability (2024) Periodic shortages Generally stable

Clinical Considerations for the Switch to Wegovy from Mounjaro

Before you switch to Wegovy from Mounjaro, your prescriber will review your treatment history, current dose, weight loss achieved, and any side effects experienced on tirzepatide. This assessment ensures Wegovy represents an appropriate alternative and identifies any contraindications specific to semaglutide, such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Blood glucose monitoring becomes particularly important for patients with type 2 diabetes who switch to Wegovy from Mounjaro, as the change in medication potency and mechanism may affect glycaemic control. Whilst both medications improve insulin sensitivity and reduce HbA1c, the transition period requires vigilance to prevent hypoglycaemia, especially in patients taking concurrent diabetes medications [7].

At Cured Pharmacy, all patients requesting to switch to Wegovy from Mounjaro undergo a comprehensive clinical assessment by our UK-registered prescribers. This ensures continuity of care, appropriate dose selection, and ongoing monitoring throughout the transition period. Wegovy is available from £124.99 subject to prescriber approval, with transparent pricing displayed before your consultation begins.

Cost Comparison: Financial Benefits of the Switch to Wegovy from Mounjaro

One of the primary drivers for patients choosing to switch to Wegovy from Mounjaro relates to cost differences between these treatments in the UK private market. Wegovy typically costs significantly less than Mounjaro at equivalent therapeutic doses, making it an economically attractive option for long-term weight management.

At Cured Pharmacy, Wegovy is available from £124.99 compared to Mounjaro from £124.99, representing substantial monthly savings when you switch to Wegovy from Mounjaro. Over a typical 12-month treatment course, this price difference can amount to hundreds of pounds in savings whilst maintaining comparable clinical efficacy for weight reduction.

Additionally, new patients switching to Wegovy from Mounjaro can access £20 off their first order using code Weightlossnew, further reducing initial treatment costs. Our transparent pricing model ensures you know the exact cost before completing your clinical assessment, with no hidden fees or unexpected charges.

Long-Term Value When You Switch to Wegovy from Mounjaro

Beyond immediate cost savings, the switch to Wegovy from Mounjaro may offer improved long-term value through established supply chains and broader availability across UK pharmacies. Wegovy's longer market presence in the UK weight management sector has resulted in more stable supply compared to periodic Mounjaro shortages experienced throughout 2023-2024.

For patients planning extended treatment duration—often 12-24 months or longer for sustained weight management—the cumulative savings when you switch to Wegovy from Mounjaro become increasingly significant. These financial benefits support treatment adherence and reduce the likelihood of discontinuation due to cost pressures, ultimately improving long-term weight loss outcomes [8].

What to Expect After You Switch to Wegovy from Mounjaro

Most patients who switch to Wegovy from Mounjaro maintain their weight loss trajectory without significant disruption, provided appropriate dose conversion protocols are followed. During the first 4-8 weeks following the switch to Wegovy from Mounjaro, you may notice subtle differences in appetite suppression patterns, injection site reactions, or gastrointestinal symptoms as your body adapts to semaglutide.

Appetite control typically remains consistent when you switch to Wegovy from Mounjaro, though some patients report the subjective 'feel' of satiety differs slightly between the medications. These differences rarely impact overall efficacy, with most patients continuing to lose weight or maintain their achieved weight loss throughout the transition period and beyond.

Regular follow-up with your prescriber during the first three months after you switch to Wegovy from Mounjaro ensures optimal dose titration and allows prompt management of any emerging side effects. At Cured Pharmacy, our clinical team remains available for ongoing support throughout your treatment journey, with straightforward access to prescription renewals and dose adjustments as needed.

Scientific References

  1. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 15 August 2026]
  2. Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  3. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  4. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
  5. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
  6. Blundell, J., Finlayson, G., Axelsen, M., et al. (2017). Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes, Obesity and Metabolism, 19(9), 1242-1251. [accessed 15 August 2026]
  7. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet, 397(10278), 971-984. [accessed 15 August 2026]
  8. Wadden, T. A., Bailey, T. S., Billings, L. K., et al. (2021). Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity. JAMA, 325(14), 1403-1413. [accessed 15 August 2026]
  9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can I switch to Wegovy from Mounjaro immediately or do I need a break between medications?
You can typically switch to Wegovy from Mounjaro without a break period—most UK prescribers recommend starting Wegovy the week after your last Mounjaro injection to maintain continuous appetite suppression and weight management benefits.
Will I regain weight when I switch to Wegovy from Mounjaro?
Most patients maintain their weight loss trajectory when they switch to Wegovy from Mounjaro, provided appropriate dose conversion is followed. Both medications work through similar GLP-1 pathways, supporting continued weight management during and after the transition.
How long does nausea last after switching to Wegovy from Mounjaro?
Nausea during the switch to Wegovy from Mounjaro typically peaks within 2-3 days of each injection and subsides within 5-7 days as your body adapts. Following dietary modifications and conservative dose escalation significantly reduces nausea severity and duration.
What dose of Wegovy equals Mounjaro 5mg?
There is no exact dose equivalence when you switch to Wegovy from Mounjaro 5mg, but most UK prescribers start patients at Wegovy 0.5mg or 1mg, titrating upward based on individual response and tolerability rather than attempting direct milligram conversion.
Is Wegovy as effective as Mounjaro for weight loss?
Clinical trials show both medications achieve substantial weight loss, with Wegovy producing 15-17% average reduction and Mounjaro 15-22% depending on dose. Most patients who switch to Wegovy from Mounjaro maintain comparable weight loss outcomes at appropriate therapeutic doses.
Do I need a new prescription to switch to Wegovy from Mounjaro?
Yes, switching to Wegovy from Mounjaro requires a new prescription from a UK-registered prescriber. At Cured Pharmacy, our clinical team can assess your suitability during a brief online consultation, with Wegovy available from £124.99 subject to approval.
Can I switch back to Mounjaro if Wegovy doesn't suit me?
You can switch back to Mounjaro if you experience tolerability issues with Wegovy, subject to prescriber assessment. However, most patients who switch to Wegovy from Mounjaro tolerate semaglutide well, particularly when following conservative dose escalation protocols.
How much money will I save if I switch to Wegovy from Mounjaro?
At Cured Pharmacy, switching to Wegovy from Mounjaro saves approximately £124.99 per month (Wegovy from £124.99 vs Mounjaro from £124.99), plus an additional £20 off your first order with code Weightlossnew—substantial savings over typical 12-24 month treatment courses.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.